JP2016503416A5 - - Google Patents

Download PDF

Info

Publication number
JP2016503416A5
JP2016503416A5 JP2015542208A JP2015542208A JP2016503416A5 JP 2016503416 A5 JP2016503416 A5 JP 2016503416A5 JP 2015542208 A JP2015542208 A JP 2015542208A JP 2015542208 A JP2015542208 A JP 2015542208A JP 2016503416 A5 JP2016503416 A5 JP 2016503416A5
Authority
JP
Japan
Prior art keywords
composition
cyclodextrin
administration
group
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015542208A
Other languages
English (en)
Japanese (ja)
Other versions
JP6235603B2 (ja
JP2016503416A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/072856 external-priority patent/WO2014075935A1/de
Publication of JP2016503416A publication Critical patent/JP2016503416A/ja
Publication of JP2016503416A5 publication Critical patent/JP2016503416A5/ja
Application granted granted Critical
Publication of JP6235603B2 publication Critical patent/JP6235603B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015542208A 2012-11-15 2013-11-01 消炎性および/または免疫抑制性活性成分としてのデルフィニジン複合体 Active JP6235603B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12192717 2012-11-15
EP12192717.2 2012-11-15
PCT/EP2013/072856 WO2014075935A1 (de) 2012-11-15 2013-11-01 Delphinidinkomplex als antiphlogistischer oder immunsuppressiver wirkstoff

Publications (3)

Publication Number Publication Date
JP2016503416A JP2016503416A (ja) 2016-02-04
JP2016503416A5 true JP2016503416A5 (https=) 2016-11-10
JP6235603B2 JP6235603B2 (ja) 2017-11-22

Family

ID=47189771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015542208A Active JP6235603B2 (ja) 2012-11-15 2013-11-01 消炎性および/または免疫抑制性活性成分としてのデルフィニジン複合体

Country Status (8)

Country Link
US (1) US9925274B2 (https=)
EP (1) EP2919791B1 (https=)
JP (1) JP6235603B2 (https=)
KR (1) KR102147084B1 (https=)
CN (1) CN104870001B (https=)
CA (1) CA2890022C (https=)
DK (1) DK2919791T3 (https=)
WO (1) WO2014075935A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014075935A1 (de) 2012-11-15 2014-05-22 Sapiotec Gmbh Delphinidinkomplex als antiphlogistischer oder immunsuppressiver wirkstoff
US9949947B2 (en) 2012-12-11 2018-04-24 Sapiotec Gmbh Delphinidin for combating melanoma cells
CN106361755A (zh) * 2016-10-23 2017-02-01 徐州诺克非医药科技有限公司 含Zoarenone用于治疗溃疡性结肠炎的药物
WO2022050431A1 (ko) * 2020-09-01 2022-03-10 경상국립대학교병원 골관절염 예방 또는 치료용 약학 조성물 및 건강기능식품

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946228A (ja) 1982-09-08 1984-03-15 Zeria Shinyaku Kogyo Kk 生物学的に活性な有機化合物の水溶性及びリンパ移行性薬剤の製造方法
HU199444B (en) 1985-09-10 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom
GB8907008D0 (en) 1989-03-28 1989-05-10 Inverni Della Beffa Spa Intermediates useful for the synthesis for delphinidin chloride
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
GB2307176A (en) 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
HUP9701945A3 (en) 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
JP4101346B2 (ja) 1998-02-18 2008-06-18 ダイセル化学工業株式会社 酸化触媒系及びそれを用いた酸化方法
CA2320772A1 (en) 1998-02-23 1999-08-26 Cyclops, Ehf. High-energy cyclodextrin complexes
US6699849B1 (en) 1998-02-23 2004-03-02 Cyclops, Ehf. Cyclodextrin complexes of benzodiazepines
GB2350297A (en) 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
AU6527300A (en) 1999-08-11 2001-03-05 Josef Pitha Potentiation of inclusion complex formation of cyclodextrin derivatives
AU7937500A (en) 1999-10-27 2001-05-08 Farmarc Nederland Bv Pharmaceutical composition containing midazolam
ES2250460T3 (es) 2000-09-12 2006-04-16 Meiji Seika Kaisha, Ltd. Procedimiento para la preparacion de glucosido de antocianidina purificado.
JP4334229B2 (ja) 2001-03-20 2009-09-30 サイデックス・ファーマシューティカルズ・インコーポレイテッド プロポフォール及びスルホアルキルエーテルシクロデキストリン含有製剤
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
JP2003171274A (ja) 2001-12-07 2003-06-17 Tomihiko Higuchi 薬剤耐性菌感染症治療のための医薬組成物および消毒剤
BR0307518A (pt) 2002-02-01 2004-12-28 Shimoda Biotech Pty Ltd Composição farmacêutica
US6869939B2 (en) * 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
JP2004238336A (ja) * 2003-02-07 2004-08-26 Sanei Gen Ffi Inc 水易溶性包接フラボノイド類の製造方法
US20050013880A1 (en) 2003-03-06 2005-01-20 Magnuson Bernadene Ann Anthocyanin-rich compositions and methods for inhibiting cancer cell growth
HRP20050924A2 (en) 2003-03-28 2006-08-31 Ivax Corporation Cladribine formulations for improved oral and transmucosal delivery
JPWO2005067905A1 (ja) 2004-01-14 2007-12-27 株式会社大塚製薬工場 プロポフォール含有脂肪乳剤
CN1317961C (zh) 2004-03-25 2007-05-30 吴朝琴 冻干草莓加工工艺
WO2006076387A2 (en) 2005-01-11 2006-07-20 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Cyanidin-3-glucoside as an anti-neoplastic agent
DE102005017775A1 (de) 2005-04-13 2006-10-19 Schering Ag Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins
KR100733913B1 (ko) * 2005-08-30 2007-07-02 한국화학연구원 안토시아닌을 포함하는 뇌세포 보호제와 뇌경색 및 뇌졸중예방 또는 치료제
US7645748B2 (en) 2006-04-03 2010-01-12 Forbes Medi-Tech Inc. Sterol/stanol phosphorylnitroderivatives and use thereof
WO2008070490A2 (en) 2006-11-28 2008-06-12 Wisconsin Alumni Research Foundation Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
KR100756656B1 (ko) * 2006-12-12 2007-09-10 한국화학연구원 안토시아닌을 포함하는 뇌경색 또는 뇌졸중 예방 및 개선용건강식품
KR100880876B1 (ko) * 2007-04-11 2009-01-30 경상대학교산학협력단 검정콩 껍질로부터 추출한 안토시아닌을 함유하는 피판이나조직의 허혈-재관류 손상의 예방 또는 치료용 의약 조성물
WO2009018326A2 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Soluble pyrone analogs methods and compositions
JP5574600B2 (ja) * 2007-12-17 2014-08-20 日本製薬工業株式会社 吸収性骨疾患の予防・治療剤
EP2106786A1 (de) 2008-04-04 2009-10-07 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US20120083460A1 (en) 2009-03-25 2012-04-05 San Ei Gen F.F.I., Inc. Readily water-soluble isoquercitrin composition
EP2437770A4 (en) 2009-06-05 2013-11-06 Univ Colorado Regents ANTIMICROBIAL PEPTIDES
EP2344154B1 (en) 2009-10-21 2016-12-07 Maqui New Life S.A. Compositions that include anthocyanidins and methods of use
EP2345427A1 (de) 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
CN102892310B (zh) 2010-03-13 2016-07-06 伊斯顿庞德实验室有限公司 结合脂肪的组合物
DE102010042615A1 (de) 2010-10-19 2012-04-19 Wacker Chemie Ag 1:1, 2:1- oder 3:1-Komplex bestehend aus einem Cyclodextrin oder Cyclodextrinderivat und einem halogeniertem Ether, seine Herstellung und seine Verwendung als Schlafmittel
AU2010366535A1 (en) 2010-12-31 2013-07-11 Eastpond Laboratories Limited Cellular hydration compositions containing cyclodextrins
DK2484350T3 (en) 2011-02-04 2016-08-01 Norbert Univ -Prof Dr Med Roewer A pharmaceutical composition containing a complex of a cyclodextrin with a propofolsalt
JP6193970B2 (ja) 2012-03-30 2017-09-06 ザピオテック・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングSAPIOTEC GmbH 黄色ブドウ球菌(Staphylococcusaureus)に対するデルフィニジンの使用
CA2869056C (en) 2012-03-30 2020-02-25 Sapiotec Gmbh Anthocyanidin complex
CN104780925A (zh) * 2012-10-17 2015-07-15 赛博尔泰克股份公司 用于治疗多发性骨髓瘤的花青素络合物
WO2014075935A1 (de) 2012-11-15 2014-05-22 Sapiotec Gmbh Delphinidinkomplex als antiphlogistischer oder immunsuppressiver wirkstoff
US9949947B2 (en) 2012-12-11 2018-04-24 Sapiotec Gmbh Delphinidin for combating melanoma cells
EP2913050A1 (de) 2014-02-28 2015-09-02 SapioTec GmbH Verfahren zur Herstellung eines Flurankomplexes
EP2913366A1 (de) 2014-02-28 2015-09-02 SapioTec GmbH Anthocyanidin-Komplex

Similar Documents

Publication Publication Date Title
JP2012092123A5 (https=)
JP2016503416A5 (https=)
JP2013505205A5 (https=)
JP2016512248A5 (https=)
JP2015212268A5 (https=)
FI2291080T5 (fi) Uusia sfingosiinifosfaattireseptorimodulaattoreita
FI3562486T3 (fi) Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa
JP2015500885A5 (https=)
RU2015146957A (ru) Производные доластатина 10 и ауристатинов
JP2016515561A5 (https=)
JP2015534578A5 (https=)
JP2016506941A5 (https=)
JP2012502037A5 (https=)
IL314873A (en) Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
JP2012140433A5 (https=)
JP2011522816A5 (https=)
NZ598428A (en) Stabilized amorphous forms of imatinib mesylate which is formulated by co-milling with excipients
JP2016517421A5 (https=)
JP2019534265A5 (ja) 医薬組成物およびその投与方法
JP2015510916A5 (https=)
CO6400183A2 (es) Formas de dosificación oral de bendamustina
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2015506363A5 (https=)
JP2016509051A5 (https=)
JP2015514739A5 (https=)